tiprankstipranks
Trending News
More News >
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market
Advertisement

AstraZeneca Pharma India Limited (ASTRAZEN) Ratios

Compare
21 Followers

AstraZeneca Pharma India Limited Ratios

IN:ASTRAZEN's free cash flow for Q3 2025 was ₹0.44. For the 2025 fiscal year, IN:ASTRAZEN's free cash flow was decreased by ₹ and operating cash flow was ₹0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.91 2.61 2.61 2.18 2.12
Quick Ratio
1.13 1.97 1.97 1.68 1.70
Cash Ratio
0.76 1.42 1.42 1.30 1.35
Solvency Ratio
0.32 0.48 0.48 0.29 0.23
Operating Cash Flow Ratio
0.00 0.08 0.08 0.15 0.30
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -6.59 -4.82
Net Current Asset Value
₹ 5.95B₹ 5.67B₹ 5.67B₹ 4.39B₹ 3.60B
Leverage Ratios
Debt-to-Assets Ratio
0.02 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.05 <0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
0.04 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.97 1.51 1.51 1.67 1.67
Debt Service Coverage Ratio
28.51 148.04 148.04 -14.14 -3.98
Interest Coverage Ratio
118.04 142.86 372.82 149.26 85.75
Debt to Market Cap
<0.01 0.00 0.00 >-0.01 >-0.01
Interest Debt Per Share
15.12 2.32 2.32 3.14 3.83
Net Debt to EBITDA
-1.66 -2.13 -2.13 -3.27 -4.36
Profitability Margins
Gross Profit Margin
44.59%48.03%48.03%54.37%55.63%
EBIT Margin
13.38%17.04%17.04%13.43%10.43%
EBITDA Margin
16.22%18.19%18.19%15.05%12.53%
Operating Profit Margin
13.17%13.23%34.53%9.42%10.11%
Pretax Profit Margin
13.27%16.95%16.95%13.37%10.31%
Net Profit Margin
9.88%12.47%12.47%9.90%7.65%
Continuous Operations Profit Margin
9.88%12.47%12.47%9.90%7.65%
Net Income Per EBT
74.47%73.57%73.57%74.04%74.18%
EBT Per EBIT
100.77%128.06%49.07%141.90%101.94%
Return on Assets (ROA)
12.08%14.98%14.98%10.08%7.19%
Return on Equity (ROE)
25.82%22.69%22.69%16.87%12.05%
Return on Capital Employed (ROCE)
29.98%23.78%62.06%15.73%15.55%
Return on Invested Capital (ROIC)
21.98%17.45%45.54%11.75%11.93%
Return on Tangible Assets
12.08%15.01%15.01%10.16%7.19%
Earnings Yield
0.82%1.24%1.24%1.22%0.97%
Efficiency Ratios
Receivables Turnover
10.02 7.65 8.46 8.48 9.38
Payables Turnover
2.25 3.43 3.43 2.01 1.88
Inventory Turnover
1.87 2.95 2.95 2.41 2.55
Fixed Asset Turnover
29.18 19.98 19.98 14.29 10.50
Asset Turnover
1.22 1.20 1.20 1.02 0.94
Working Capital Turnover Ratio
5.80 2.52 2.52 2.43 2.34
Cash Conversion Cycle
69.17 64.71 60.15 13.02 -12.36
Days of Sales Outstanding
36.44 47.70 43.14 43.06 38.91
Days of Inventory Outstanding
194.75 123.54 123.54 151.69 143.18
Days of Payables Outstanding
162.02 106.54 106.54 181.73 194.46
Operating Cycle
231.19 171.24 166.69 194.75 182.09
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 11.15 11.15 23.32 40.32
Free Cash Flow Per Share
0.00 6.84 6.84 19.91 36.47
CapEx Per Share
0.00 4.30 4.30 3.41 3.85
Free Cash Flow to Operating Cash Flow
0.00 0.61 0.61 0.85 0.90
Dividend Paid and CapEx Coverage Ratio
0.00 0.55 0.55 2.04 6.89
Capital Expenditure Coverage Ratio
0.00 2.59 2.59 6.84 10.48
Operating Cash Flow Coverage Ratio
0.00 6.07 6.07 8.08 11.68
Operating Cash Flow to Sales Ratio
0.00 0.02 0.02 0.06 0.13
Free Cash Flow Yield
0.00%0.13%0.13%0.61%1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
121.71 80.50 80.50 81.90 103.57
Price-to-Sales (P/S) Ratio
12.03 10.04 10.04 8.11 7.92
Price-to-Book (P/B) Ratio
28.97 18.26 18.26 13.81 12.48
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 759.88 759.88 163.37 69.97
Price-to-Operating Cash Flow Ratio
0.00 466.51 466.51 139.49 63.29
Price-to-Earnings Growth (PEG) Ratio
2.08 1.29 1.29 1.34 -3.05
Price-to-Fair Value
28.97 18.26 18.26 13.81 12.48
Enterprise Value Multiple
72.49 53.04 53.04 50.59 58.85
Enterprise Value
218.15B 125.01B 125.01B 76.39B 59.40B
EV to EBITDA
72.49 53.04 53.04 50.59 58.85
EV to Sales
11.76 9.65 9.65 7.62 7.37
EV to Free Cash Flow
0.00 730.60 730.60 153.46 65.14
EV to Operating Cash Flow
0.00 448.53 448.53 131.03 58.93
Tangible Book Value Per Share
307.85 283.92 283.92 235.48 204.56
Shareholders’ Equity Per Share
308.11 284.77 284.77 235.48 204.56
Tax and Other Ratios
Effective Tax Rate
0.26 0.26 0.26 0.26 0.26
Revenue Per Share
741.97 518.21 518.21 401.19 322.24
Net Income Per Share
73.34 64.60 64.60 39.72 24.64
Tax Burden
0.74 0.74 0.74 0.74 0.74
Interest Burden
0.99 0.99 0.99 1.00 0.99
Research & Development to Revenue
0.00 0.00 0.00 0.06 0.05
SG&A to Revenue
0.04 0.03 0.03 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.00 0.17 0.17 0.43 1.21
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis